Aadi Bioscience Inc reports results for the quarter ended in June - Earnings Summary
07/08/2024 14:32
* Aadi Bioscience Inc AADI.OQ reported a quarterly
adjusted loss
of 54 cents per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -67 cents. The mean expectation of five analysts for the
quarter was for a loss of 69 cents per share. Wall Street
expected results to range from -77 cents to -61 cents per share.
* Revenue fell 0.4% to $6.18 million from a year ago;
analysts
expected $6.20 million.
* Aadi Bioscience Inc's reported EPS for the quarter was a
loss
of 54 cents.
* The company reported a quarterly loss of $14.58 million.
* Aadi Bioscience Inc shares had fallen by 4.1% this
quarter and
lost 30.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Aadi Bioscience
Inc is $14.00
This summary was machine generated from LSEG data August 7 at
01:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.64 -0.54 Beat
Mar. 31 2024 -0.64 -0.68 Missed
Dec. 31 2023 -0.65 -0.60 Beat
Sep. 30 2023 -0.72 -0.60 Beat